National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 55086 [2013-21789]
Download as PDF
<![CDATA[
55086
Federal Register / Vol. 78, No. 174 / Monday, September 9, 2013 / Notices
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meeting
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIDDK.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Diabetes and
Digestive and Kidney Diseases,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDDK.
Date: October 10–11, 2013.
Open: October 10, 2013, 8:00 a.m. to 8:30
a.m.
Agenda: Introductions and Overview.
Place: National Institutes of Health,
Building 5, Room 127, 5 Memorial Drive,
Bethesda, MD 20892.
Closed: October 10, 2013, 8:30 a.m. to 3:15
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 5, Room 127, 5 Memorial Drive,
Bethesda, MD 20892.
Closed: October 11, 2013, 8:30 a.m. to 3:15
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 5, Room 127, 5 Memorial Drive,
Bethesda, MD 20892.
Contact Person: MICHAEL W. KRAUSE,
Ph.D., SCIENTIFIC DIRECTOR, NATIONAL
INSTITUTE OF DIABETES AND DIGESTIVE
AND KIDNEY DISEASES, NATIONAL
INSTITUTE OF HEALTH, BUILDING 5,
ROOM B104, Bethesda, MD 20892–1818,
(301) 402–4633, mwkrause@helix.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
VerDate Mar<15>2010
15:01 Sep 06, 2013
Jkt 229001
Dated: September 3, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–21789 Filed 9–6–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Immunology
Integrated Review Group; Hypersensitivity,
Autoimmune, and Immune-mediated
Diseases Study Section.
Date: October 3–4, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal City Marriott, 1999 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Bahiru Gametchu, DVM,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4204,
MSC 7812, Bethesda, MD 20892, 301–408–
9329, gametchb@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Clinical and Integrative
Cardiovascular Sciences Study Section.
Date: October 3, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Kabuki, 1625 Post Street, San
Francisco, CA 94115.
Contact Person: Delvin R Knight, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194
MSC 4128, Bethesda, MD 20892–7814,
301.435.1850, knightdr@csr.nih.gov.
Name of Committee: Emerging
Technologies and Training Neurosciences
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Integrated Review Group; Bioengineering of
Neuroscience, Vision and Low Vision
Technologies Study Section.
Date: October 3–4, 2013.
Time: 8:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Hilton, 1919
Connecticut Avenue, Washington, DC 20009.
Contact Person: Robert C Elliott, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5190,
MSC 7846, Bethesda, MD 20892, 301–435–
3009, elliotro@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Macromolecular Structure
and Function A Study Section.
Date: October 3, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: George Washington University Inn,
824 New Hampshire Avenue NW.,
Washington, DC 20037.
Contact Person: David R. Jollie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4150,
MSC 7806, Bethesda, MD 20892, (301)-435–
1722, jollieda@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Biomaterials and Biointerfaces Study
Section.
Date: October 3–4, 2013.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Arlington Capitol
View; 2850 South Potomac Avenue,
Arlington, VA 22202.
Contact Person: Joseph D Mosca, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158,
MSC 7808, Bethesda, MD 20892, (301) 408–
9465, moscajos@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Biophysics of Neural Systems
Study Section.
Date: October 3, 2013.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco, 2 North Charles
Street, Baltimore, MD 21201.
Contact Person: Geoffrey G Schofield,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040–A,
MSC 7850, Bethesda, MD 20892, 301–435–
1235, geoffreys@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Cellular
Mechanisms in Aging and Development
Study Section.
Date: October 3–4, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
E:\FR\FM\09SEN1.SGM
09SEN1
]]>Agencies
[Federal Register Volume 78, Number 174 (Monday, September 9, 2013)]
[Notices]
[Page 55086]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-21789]
[[Page 55086]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, NIDDK.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Diabetes and Digestive and Kidney Diseases, including
consideration of personnel qualifications and performance, and the
competence of individual investigators, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, NIDDK.
Date: October 10-11, 2013.
Open: October 10, 2013, 8:00 a.m. to 8:30 a.m.
Agenda: Introductions and Overview.
Place: National Institutes of Health, Building 5, Room 127, 5
Memorial Drive, Bethesda, MD 20892.
Closed: October 10, 2013, 8:30 a.m. to 3:15 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 5, Room 127, 5
Memorial Drive, Bethesda, MD 20892.
Closed: October 11, 2013, 8:30 a.m. to 3:15 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 5, Room 127, 5
Memorial Drive, Bethesda, MD 20892.
Contact Person: MICHAEL W. KRAUSE, Ph.D., SCIENTIFIC DIRECTOR,
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES,
NATIONAL INSTITUTE OF HEALTH, BUILDING 5, ROOM B104, Bethesda, MD
20892-1818, (301) 402-4633, mwkrause@helix.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: September 3, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-21789 Filed 9-6-13; 8:45 am]
BILLING CODE 4140-01-P
